А. В. Алешкин

623 total citations
54 papers, 466 citations indexed

About

А. В. Алешкин is a scholar working on Ecology, Infectious Diseases and Epidemiology. According to data from OpenAlex, А. В. Алешкин has authored 54 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ecology, 10 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in А. В. Алешкин's work include Bacteriophages and microbial interactions (22 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). А. В. Алешкин is often cited by papers focused on Bacteriophages and microbial interactions (22 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). А. В. Алешкин collaborates with scholars based in Russia, Germany and Bulgaria. А. В. Алешкин's co-authors include Л. Б. Бойнович, Kirill A. Emelyanenko, Alexandre M. Emelyanenko, И. А. Киселева, Alexander G. Domantovsky, Evgeny Modin, Nikolay V. Volozhantsev, А. В. Караулов, Elizaveta V. Chulkova and Anastasiya V. Popova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Langmuir and Scientific Reports.

In The Last Decade

А. В. Алешкин

44 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. В. Алешкин Russia 11 213 118 93 84 74 54 466
Binu Kundukad Singapore 15 68 0.3× 353 3.0× 216 2.3× 35 0.4× 28 0.4× 26 764
N. G. Cogan United States 17 100 0.5× 373 3.2× 220 2.4× 51 0.6× 16 0.2× 52 889
Luis A. Estrella United States 11 128 0.6× 122 1.0× 31 0.3× 37 0.4× 69 0.9× 16 397
Suriani Abdul Rani United States 7 77 0.4× 381 3.2× 113 1.2× 17 0.2× 69 0.9× 10 616
Ronn S. Friedlander United States 7 54 0.3× 315 2.7× 223 2.4× 223 2.7× 51 0.7× 7 781
Martin Metzner Germany 13 45 0.2× 160 1.4× 19 0.2× 37 0.4× 66 0.9× 33 560
Michael A. Welsh United States 16 168 0.8× 727 6.2× 134 1.4× 199 2.4× 131 1.8× 17 1.2k
Dieter Wirz Switzerland 18 67 0.3× 169 1.4× 288 3.1× 16 0.2× 34 0.5× 38 1.2k
Honglan Huang China 14 46 0.2× 172 1.5× 40 0.4× 46 0.5× 26 0.4× 42 475
Connie B. Chang United States 14 116 0.5× 300 2.5× 298 3.2× 30 0.4× 11 0.1× 16 931

Countries citing papers authored by А. В. Алешкин

Since Specialization
Citations

This map shows the geographic impact of А. В. Алешкин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. В. Алешкин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. В. Алешкин more than expected).

Fields of papers citing papers by А. В. Алешкин

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. В. Алешкин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. В. Алешкин. The network helps show where А. В. Алешкин may publish in the future.

Co-authorship network of co-authors of А. В. Алешкин

This figure shows the co-authorship network connecting the top 25 collaborators of А. В. Алешкин. A scholar is included among the top collaborators of А. В. Алешкин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. В. Алешкин. А. В. Алешкин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasina, Daria V., Igor V. Grigoriev, Evgeny V. Usachev, et al.. (2024). Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application. Journal of Pharmaceutical Sciences. 113(8). 2093–2100.
2.
Fedorova, I. M., et al.. (2021). Phage therapy in antibiotic resistant pneumonia: immunomodulation or redistribution?. SHILAP Revista de lepidopterología. 23(1). 179–184.
3.
Алешкин, А. В., et al.. (2021). Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection. Bulletin of Experimental Biology and Medicine. 171(2). 230–233. 3 indexed citations
4.
Emelyanenko, Alexandre M., et al.. (2020). Antibacterial Properties of Superhydrophilic Textured Copper in Contact with Bacterial Suspensions. Bulletin of Experimental Biology and Medicine. 168(4). 488–491. 11 indexed citations
5.
Караулов, А. В., et al.. (2020). Analysis of the Pharmacokinetics of Suppository Forms of Bacteriophages. Bulletin of Experimental Biology and Medicine. 168(6). 748–752. 7 indexed citations
6.
Бойнович, Л. Б., Alexander G. Domantovsky, Kirill A. Emelyanenko, et al.. (2019). Bactericidal Activity of Superhydrophobic and Superhydrophilic Copper in Bacterial Dispersions. Langmuir. 35(7). 2832–2841. 46 indexed citations
7.
Emelyanenko, Alexandre M., Elizaveta V. Chulkova, Alexander G. Domantovsky, et al.. (2019). Superhydrophobic copper in biological liquids: Antibacterial activity and microbiologically induced or inhibited corrosion. Colloids and Surfaces B Biointerfaces. 185. 110622–110622. 53 indexed citations
8.
Алешкин, А. В., Evgeny Modin, Erin C. Boyle, et al.. (2019). Fibrin glue as a local drug-delivery system for bacteriophage PA5. Scientific Reports. 9(1). 2091–2091. 52 indexed citations
9.
Караулов, А. В., et al.. (2019). APPROACHES TO THE ESTIMATION OF SOME PARAMETERS OF HUMORAL AND CELLULAR IMMUNE RESPONSE TO BACTERIOPHAGES. Russian Clinical Laboratory Diagnostics. 64(4). 237–242. 3 indexed citations
10.
Бойнович, Л. Б., Evgeny Modin, А. В. Алешкин, et al.. (2018). Effective Antibacterial Nanotextured Surfaces Based on Extreme Wettability and Bacteriophage Seeding. ACS Applied Nano Materials. 1(3). 1348–1359. 48 indexed citations
11.
Алешкин, А. В., et al.. (2018). CONCEPT OF PERSONALIZED PHAGE THERAPY FOR INTENSIVE CARE UNIT PATIENTS WITH HEALTHCARE-ASSOCIATED INFECTIONS. Fundamental and Clinical Medicine. 3(2). 66–74. 6 indexed citations
12.
Алешкин, А. В., et al.. (2018). Experimental Application of Organic-Inorganic Hybrid Coatings with Adsorbed Bacteriophages for Reducing the Risk of STEC Infections. Bulletin of Experimental Biology and Medicine. 165(4). 478–481. 2 indexed citations
13.
Караулов, А. В., et al.. (2018). The role of innate immunity receptors in infectious diseases and maintenance of organism homeostasis. Infekcionnye bolezni. 16(1). 70–78.
14.
Хавкин, А. И., et al.. (2018). Potential of phage therapy in digestive diseases in children. Voprosy praktičeskoj pediatrii. 13(4). 82–90. 3 indexed citations
15.
Караулов, А. В., et al.. (2018). TLRs-dependence of infection by viruses of the Herpesviridae family in urogenital infection of pregnant women. Voprosy ginekologii akušerstva i perinatologii. 17(3). 33–40. 1 indexed citations
17.
Алешкин, А. В., et al.. (2016). Bacteriophages in therapy and prevention of acute intestinal infections in children. Voprosy praktičeskoj pediatrii. 2016(1). 52–56. 1 indexed citations
18.
Алешкин, А. В.. (2015). Исторический обзор опыта применения бактериофагов в России. SHILAP Revista de lepidopterología. 12–17. 1 indexed citations
19.
Алешкин, А. В., et al.. (2012). Interaction of Probiotic Bacterial Lectins to Candida species. 29(2012).
20.
Алешкин, А. В., et al.. (2010). Вторичная лактазная недостаточность в клинике ротавирусных кишечных инфекций у детей. Practical medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026